| Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and … J Delgado, M Doubek, T Baumann, J Kotaskova, S Molica, P Mozas, ... American journal of hematology 92 (4), 375-380, 2017 | 117 | 2017 |
| Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ... Annals of Oncology 29 (12), 2363-2370, 2018 | 113 | 2018 |
| Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ... Annals of Oncology, 2018 | 113 | 2018 |
| Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ... Blood 128 (23), 2666-2670, 2016 | 98 | 2016 |
| Distinct molecular profile of IRF4-rearranged large B-cell lymphoma JE Ramis-Zaldivar, B Gonzalez-Farré, O Balagué, V Celis, F Nadeu, ... Blood, The Journal of the American Society of Hematology 135 (4), 274-286, 2020 | 89 | 2020 |
| Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era A Rivas‐Delgado, L Magnano, M Moreno‐Velázquez, O Garcia, F Nadeu, ... British journal of haematology 184 (5), 753-759, 2019 | 73 | 2019 |
| Detection of early seeding of Richter transformation in chronic lymphocytic leukemia F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ... Nature medicine 28 (8), 1662-1671, 2022 | 66 | 2022 |
| Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions A Puiggros, R Collado, MJ Calasanz, M Ortega, N Ruiz-Xivillé, ... Oncotarget 8 (33), 54297, 2017 | 61 | 2017 |
| The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome M Duran-Ferrer, G Clot, F Nadeu, R Beekman, T Baumann, J Nordlund, ... Nature Cancer 1 (11), 1066-1081, 2020 | 54 | 2020 |
| Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study A Rivas-Delgado, F Nadeu, A Enjuanes, S Casanueva-Eliceiry, P Mozas, ... Clinical Cancer Research 27 (2), 513-521, 2021 | 53 | 2021 |
| High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and … I Dlouhy, X Filella, J Rovira, L Magnano, A Rivas-Delgado, T Baumann, ... Leukemia research 59, 20-25, 2017 | 51 | 2017 |
| Clinical impact of a 6-week preoperative very low calorie diet on body weight and liver size in morbidly obese patients J González-Pérez, S Sánchez-Leenheer, AR Delgado, ... Obesity surgery 23, 1624-1631, 2013 | 51 | 2013 |
| The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma JG Valero, A Matas-Céspedes, F Arenas, V Rodriguez, J Carreras, ... Leukemia 35 (9), 2635-2649, 2021 | 40 | 2021 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British journal of haematology 185 (3), 480-491, 2019 | 36 | 2019 |
| Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study A Cuneo, G Follows, GM Rigolin, A Piciocchi, A Tedeschi, L Trentin, ... haematologica 103 (7), 1209-1217, 2018 | 36 | 2018 |
| IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms F Nadeu, R Mas-de-Les-Valls, A Navarro, R Royo, S Martín, N Villamor, ... Nature communications 11 (1), 3390, 2020 | 32 | 2020 |
| PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax N Serrat, M Guerrero-Hernández, A Matas-Céspedes, A Yahiaoui, ... Blood advances 4 (17), 4217-4231, 2020 | 28 | 2020 |
| Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience P Mozas, F Nadeu, A Rivas-Delgado, A Rivero, M Garrote, O Balagué, ... Blood cancer journal 10 (3), 31, 2020 | 26 | 2020 |
| Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma L Magnano, O Balagué, I Dlouhy, J Rovira, K Karube, M Pinyol, ... Annals of Oncology 28 (11), 2799-2805, 2017 | 26 | 2017 |
| Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation G Bastidas‐Mora, S Beà, A Navarro, E Gine, D Costa, J Delgado, ... British Journal of Haematology 196 (1), 146-155, 2022 | 20 | 2022 |
Laura MagnanoHospital Clínic de BarcelonaVerified email at clinic.ub.es
